Project background
And meta Biotechnology (Shanghai) Limited by Share Ltd (hereinafter referred to as "company" or "yuan Shanghai") is a leading domestic high-tech enterprise with three major development directions, including basic research services, gene therapy drug development and the industrialization of clinical class recombinant virus. The company was established in March 2013, completed the share reform in December 2015, and officially launched the "new three boards" in December 2016 (short for Securities: and Yuan Shanghai, stock code 839702).）
Technology
